Table 2. Baseline characteristics of the patient cohort.
| Variables | n | % |
| Sex | ||
| male | 150 | 53.57 |
| female | 130 | 46.43 |
| Median age at diagnosis | 68.4 years,range (25.3–91.6) | |
| Grade | ||
| poorly differentiated/undifferentiated | 42 | 15.0 |
| well/moderately differentiated | 234 | 83.6 |
| unknown | 4 | 1.4 |
| Histology | ||
| mucinous | 43 | 15.4 |
| non-mucinous | 237 | 84.6 |
| Location | ||
| rectum | 57 | 20.4 |
| colon | 223 | 79.6 |
| Stage | ||
| I | 54 | 19.3 |
| II | 94 | 33.6 |
| III | 76 | 27.1 |
| IV | 47 | 16.8 |
| unknown | 9 | 3.2 |
| MSI status | ||
| MSI-H | 34 | 12.1 |
| MSI-L/MSS | 246 | 87.9 |
| OS status | ||
| dead | 172 | 61.4 |
| alive | 108 | 38.6 |
| Median OS and DSS (follow up) time | 5.30 years,range (0–12.5 years) | |
| DFS status | ||
| recurrence/metastasis/death (+) | 184 | 65.7 |
| recurrence/metastasis/death (−) | 96 | 34.3 |
| DFS (follow up) time | 3.37 years,range (0–12.5 years) | |
| DSS status | ||
| death from colorectal cancer | 113 | 40.4 |
| death from other causes/alive | 167 | 59.6 |
Summary of the baseline characteristics of the study cohort. (+): present, (−): absent, DFS: disease-free survival, DSS: disease-specific survival, MSI-H: microsatellite instability-high, MSI-L: microsatellite instability-low, MSS: microsatellite stable, n: number of samples included into the analysis, OS: overall survival.